HUNNYSEChemicals & Allied ProductsFiscal year ends December 31

Huntsman CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026

$8.33−0.25 (-2.91%)

Close on Oct 19, 2026

Market cap: $1.44B
P/E (TTM): –
Dividend yield: 10.05%

Huntsman CORP income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Revenue	5,683	6,036	6,111	8,023	7,670	5,421	6,797	7,604	6,845	7,518	8,139	11,578	11,079	11,187	11,221	9,250	7,665	10,056
Cost of Revenue	4,932	5,170	5,205	6,477	6,086	4,444	5,415	5,840	5,194	6,000	6,405	9,659	9,326	9,153	9,381	7,789	6,587	8,776
Gross Profit	751	866	906	1,546	1,584	977	1,382	1,764	1,651	1,518	1,734	1,919	1,753	2,034	1,840	1,461	1,078	1,280
Research & Development	120	121	115	125	135	121	137	145	132	137	143	158	140	152	166	151	145	154
Selling, General & Admin	670	671	689	711	739	670	786	789	759	772	791	974	942	951	921	861	850	871
Operating Expenses	882	891	822	874	853	545	913	937	922	855	1,017	1,286	1,243	1,189	1,234	1,051	1,065	1,083
Operating Income	-131	-25	84	672	731	432	469	827	729	663	717	633	510	845	606	410	13	197
Interest Expense	–	–	–	–	–	–	–	–	–	–	–	–	–	–	249	229	238	262
Income from Equity Investments	4.00	44	83	67	143	42	54	55	13	5.00	6.00	6.00	8.00	7.00	8.00	24	3.00	14
Other Non-Operating Income	14	21	-3.00	20	29	31	20	32	8.00	12	1.00	-2.00	2.00	1.00	2.00	2.00	–	–
Merger & Restructuring Charges	100	10	11	80	22	34	3.00	-22	1.00	-4.00	7.00	37	13	15	60	2.00	13	–
Asset Impairment Charges	85	–	–	–	–	–	–	–	–	1.00	19	26	–	–	–	–	–	–
Gain (Loss) on Investments	–	12	-5.00	-12	-28	-88	-18	-62	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	-5.00	-1.00	0	0	30	280	-21	0	9.00	97	-1.00	3.00	-5.00	–	38	-8.00	2.00	-6.00
Legal Settlements	33	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Pretax Income	-192	-39	99	697	1,246	331	391	734	531	474	488	–	–	–	–	–	–	–
Income Tax Expense	26	61	64	186	191	42	-38	45	20	109	60	51	125	169	109	29	444	190
Income from Continuing Operations	-275	-162	-17	448	996	257	393	608	406	334	395	331	133	368	244	-14	127	511
Income from Discontinued Operations	-9.00	-27	118	12	49	777	169	-39	230	-8.00	-302	-8.00	-5.00	-7.00	-1.00	42	-19	84
Net Income incl. Noncontrolling Interests	-227	-127	153	523	1,104	1,066	598	650	741	357	126	345	149	373	254	32	112	610
Minority Interest in Earnings	57	62	52	63	59	32	36	313	105	31	33	22	21	10	7.00	5.00	-2.00	1.00
Net Income	-284	-189	101	460	1,045	1,034	562	337	636	326	93	323	128	363	247	27	114	609
Net Income to Common	–	–	–	–	–	1,034	562	337	–	–	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	-1.65	-1.10	0.57	2.29	4.77	4.69	2.46	1.42	2.67	1.38	0.38	1.33	0.53	1.53	1.04	0.11	0.49	2.62
EPS (Diluted)(per share)	-1.65	-1.10	0.57	2.27	4.72	4.66	2.44	1.39	2.61	1.36	0.38	1.31	0.53	1.51	1.02	0.11	0.48	2.60
Shares Outstanding (Basic, Weighted)(shares)	173	172	177	201	219	221	229	238	238	236	243	242	240	238	238	236	234	232
Shares Outstanding (Diluted, Weighted)(shares)	173	172	177	203	221	222	231	242	244	240	245	246	242	241	242	236	238	234
Dividend per Share(per share)	0.84	1.00	0.95	0.85	0.75	0.65	0.65	0.65	0.50	0.50	0.50	0.50	0.50	0.40	0.40	0.40	0.40	0.40
EBITDA	156	264	362	953	1,009	699	739	1,082	965	981	1,015	1,078	958	1,277	1,045	815	455	595
Net Interest Income	–	–	–	–	–	–	–	–	–	-202	-205	-205	-190	-226	-249	-229	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 13.5%
Operating margin: -0.5%
Net margin: -3.1%
Return on equity, FY2025: -9.9%

Financial strength

Current ratio: 1.33
Debt to equity: 0.78
Debt to assets: 29.0%
Cash to current liabilities: 20.1%

Valuation

P/E ratio: –
Price to sales: 0.24
Price to book: 0.54
Dividend yield: 10.05%